Scope of the Report
- The number of researchers who currently or plan to use primary cells in their research.
- Proportion of researchers/labs who purchase primary cells.
- Annual lab budget associated with primary cell purchase.
- Market size, in terms of revenue, based on 2012.
- Supplier share in terms of revenue.
- Market growth in terms of revenue in the next 12 months (through 2013).
- The different types of cells used in life science research.
- Motivation for primary cell use.
- The motivation for—or barriers preventing—the purchase of primary cells.
- The top primary cell types used.
- The leading suppliers of primary cells.
- Customer satisfaction with primary cell product offerings.
- The emerging commercial market for stem cell-derived differentiated cells by customer type, motivation for use, cell types, leading suppliers, and estimated budget.
- The Brand Share Index for leading primary cell suppliers.
- Customer loyalty and likelihood to reorder.
- Types of cells used in research
- Future plans to use primary cells
- Plans to evaluate the use of differentiated or progenitor cells derived from ECSs
- Percentage of mammalian cell culture performed by cell type
- Type of research for which primary cells are most often used
- Types of animal species from which cells are used
- Types of normal primary cells currently used in research
- Types of diseased tissue from which primary cells are derived
- Sources of primary cell types—including adult stem cells: isolated and established in the lab, obtained from a colleague or purchased from a commercial supplier
2. Experience with Primary Cell Suppliers
- Reasons NOT purchased from a commercial supplier
- Reasons purchases were made from commercial suppliers
- Format in which cells are purchased
- Average liters of medias used to culture primary cells per month
- Expected change in use of primary cells from commercial suppliers over 12 months
- Primary cell BRAND used
- Primary cell BRAND used most often
- Percentage of cultures grown using cell-specific medium from same brand from whom primary cell was purchased
3. Brand Experience with Primary Cell Suppliers
- Satisfaction with primary cells by brand and by feature
- Overall satisfaction with primary cells by brand
- Likelihood to repurchase from same brand
- Likelihood to recommend preferred brand
- Familiarity with brands
- Satisfaction with performance by brand
- Acceptability of pricing by brand
- Ease of purchase by brand
- Helpfulness of customer service and technical support by brand
4. Lab Budgets for Primary Cells
- Lab's budget for primary cells and media to culture primary cells in 2012 and projected 2013
- Percentage of 2012 budget for primary cells and media spent by brand
5. Stem Cell-Derived Differentiated Cells
- Length of time stem cell-derived differentiated cells have been used
- Type of research where stem cell–derived differentiated cells are most often used
- Reason to use/plan-to-use stem cell-derived differentiated cells
- Animal species from which differentiated cells are derived
- Types of stem cell-derived differentiated cell types used/plan-to-use
- Average number of liters of media used to culture stem cell-derived differentiated cells
- Expected changes in use of stem cell-derived differentiated cells
- Sources for differentiated stem cell-derived cell types: the lab, from colleagues or from commercial suppliers
- Brands of stem cell-derived differentiated cell products used
- Format stem cell-derived differentiated cells are purchased in
- 2012 and 2013 (projected) lab budgets for stem cell-derived differentiated cells and media to culture these cells
'The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities' takes the pulse of this dynamic market. This study seeks to identify where primary cells and primary cell suppliers fit in the universe of cells used in in vitro systems, whether or not the use of primary cells is increasing or decreasing, what cell types are used most often, how satisifed scientists are with commercially available primary cells, and what is the market size and anticipated growth rate.
Pluripotent stem cells—those capable of differentiating into any cell type—have captured the imagination of scientists across many disciplines. As cell culture know-how has evolved, better and more reproducible conditions for maintaining these cells in their pluripotent state have been developed. Concomitant with optimizing cell culture conditions to maintain pluripotency have been efforts to optimize the in vitro environment to induce differentiation to create populations of highly pure and rigorously characterized differentiated cell types, including neurons, cardiomyocytes and hepatocytes.
Because terminally differentiated cells can be used in many applications where primary cells are currently employed and because the concept is relatively new, suppliers are asking multiple questions about this technology. Are researchers responding to the availability of this new source of cells? How many? What cell types are important? Where are they obtained? How will the use of primary cells be affected by the availability of stem cell-derived differentiated cell types? 'The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities' profiles this emerging market and the role of commercial suppliers in this area.
- BD Gentest (now Corning Life Sciences)
- Cell Applications
- CET (Cell Engineering Technology)
- CellnTec Advanced Cell Systems
- Celsis IVT
- Global Stem
- Gibco (Life Technologies)
- Lifeline Cell Technology
- EMD Millipore
- QBM Cell Science
- Stemcell Technologies
- Thermo Scientific
- TRL Triangle Research Labs